Aunins John G. 4
4 · Seres Therapeutics, Inc. · Filed Nov 19, 2018
Insider Transaction Report
Form 4
Aunins John G.
CTO and EVP of Bioprocess Dev.
Transactions
- Sale
COMMON STOCK
2018-11-15$8.26/sh−14,279$117,912→ 89,532 total
Footnotes (2)
- [F1]The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 15, 2018.
- [F2]The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $8.0600 to $8.4200. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.